IIF, indirect immunofluorescence

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
I E A Hoffman, I Peene, L Meheus, T W J Huizinga, L Cebecauer, D Isenberg, K De Bosschere, F Hulstaert, E M Veys, F De Keyser

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1155-1158; DOI: 10.1136/ard.2003.013417
Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse
J-S F Sanders, M G Huitma, C G M Kallenberg, C A Stegeman

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1484-1489; DOI: 10.1136/ard.2005.046219
Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall
J Hermann, U Demel, D Stünzner, E Daghofer, G Tilz, W Graninger

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 641-643; DOI: 10.1136/ard.2004.024877
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies
Richard Watts, Suzanne Lane, Thomas Hanslik, Thomas Hauser, Bernhard Hellmich, Wenche Koldingsnes, Alfred Mahr, Mårten Segelmark, Jan W Cohen-Tervaert, David Scott

Annals of the Rheumatic Diseases Feb 2007, 66 (2) 222-227; DOI: 10.1136/ard.2006.054593

Main menu